Recommendation by the Council for Choices in Health Care in Finland (COHERE Finland)

This recommendation is no longer in force but has been replaced by a recommendation  approved by COHERE on 4 February 2022.  Link to the replacing recommendation.


Nusinersen in treating Spinal Muscular Atropy (SMA) - Approved at the meeting of COHERE on 15 March 2018.

Recommendation

Background memo Perustelumuistio (in Finnish)